The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project

Background and purpose: The impact of differences in the distribution of major cancer sites and stages at diagnosis among 4 European countries on the optimal utilization proportion (OUP) of patients who should receive external beam radiotherapy was assessed within the framework of the ESTRO-HERO pro...

Descripción completa

Detalles Bibliográficos
Autores: Borràs Andrés, Josep Maria, Barton, Michael, Grau, Cai, Corral, Julieta, Verhoeven, Rob, Lemmens, Valery, Eycken, Liesbet van, Henau, Kris, Primic-Zakelj, Maja, Strojan, Primoz, Trojanowski, Maciej, Dyzmann-Sroka, Agnieszka, Kubiak, Anna, Gasparotto, Chiara, Defourny, Noémie, Malicki, Julian, Dunscombe, Peter, Coffey, Mary, Lievens, Yolande
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2015
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/67256
Acceso en línea:https://hdl.handle.net/2445/67256
Access Level:acceso abierto
Palabra clave:Gestió hospitalària
Gestió de personal
Radioteràpia
Europa
Enquestes
Radiologia
Equipaments sanitaris
Hospital administration
Personnel management
Radiotherapy
Europe
Surveys
Radiology
Health facilities
id ES_0f5fbe56d8c00a0581745bdfa738bd01
oai_identifier_str oai:diposit.ub.edu:2445/67256
network_acronym_str ES
network_name_str España
repository_id_str
spelling The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO projectBorràs Andrés, Josep MariaBarton, MichaelGrau, CaiCorral, JulietaVerhoeven, RobLemmens, ValeryEycken, Liesbet vanHenau, KrisPrimic-Zakelj, MajaStrojan, PrimozTrojanowski, MaciejDyzmann-Sroka, AgnieszkaKubiak, AnnaGasparotto, ChiaraDefourny, NoémieMalicki, JulianDunscombe, PeterCoffey, MaryLievens, YolandeGestió hospitalàriaGestió de personalRadioteràpiaEuropaEnquestesRadiologiaEquipaments sanitarisHospital administrationPersonnel managementRadiotherapyEuropeSurveysRadiologyHealth facilitiesBackground and purpose: The impact of differences in the distribution of major cancer sites and stages at diagnosis among 4 European countries on the optimal utilization proportion (OUP) of patients who should receive external beam radiotherapy was assessed within the framework of the ESTRO-HERO project. Materials and methods: Data from Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used. Population based stages at diagnosis from the cancer registries of Belgium, Slovenia, the Greater Poland region of Poland, and The Netherlands were used to assess the OUP for each country. A sensitivity analysis was carried out. Results: The overall OUP by country varied from the lowest of 48.3% in Australia to the highest of 53.4% in Poland; among European countries the variation was limited to 3%. Cancer site specific OUPs showed differences according to the variability in stage at diagnosis across countries. The most important impact on the OUP by country was due to changes in relative frequency of tumours rather than stage at diagnosis. Conclusions: This methodology can be adapted using European data, thus facilitating the planning of resources required to cope with the demand for radiotherapy in Europe, taking into account the national variability in cancer incidence.Elsevier B.V.2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/67256Articles publicats en revistes (Ciències Clíniques)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: http://dx.doi.org/10.1016/j.radonc.2015.04.021Radiotherapy and Oncology, 2015, vol. 116, num. 1, p. 45-50http://dx.doi.org/10.1016/j.radonc.2015.04.021(c) Elsevier B.V., 2015info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/672562026-05-27T06:46:51Z
dc.title.none.fl_str_mv The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
title The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
spellingShingle The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
Borràs Andrés, Josep Maria
Gestió hospitalària
Gestió de personal
Radioteràpia
Europa
Enquestes
Radiologia
Equipaments sanitaris
Hospital administration
Personnel management
Radiotherapy
Europe
Surveys
Radiology
Health facilities
title_short The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
title_full The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
title_fullStr The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
title_full_unstemmed The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
title_sort The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
dc.creator.none.fl_str_mv Borràs Andrés, Josep Maria
Barton, Michael
Grau, Cai
Corral, Julieta
Verhoeven, Rob
Lemmens, Valery
Eycken, Liesbet van
Henau, Kris
Primic-Zakelj, Maja
Strojan, Primoz
Trojanowski, Maciej
Dyzmann-Sroka, Agnieszka
Kubiak, Anna
Gasparotto, Chiara
Defourny, Noémie
Malicki, Julian
Dunscombe, Peter
Coffey, Mary
Lievens, Yolande
author Borràs Andrés, Josep Maria
author_facet Borràs Andrés, Josep Maria
Barton, Michael
Grau, Cai
Corral, Julieta
Verhoeven, Rob
Lemmens, Valery
Eycken, Liesbet van
Henau, Kris
Primic-Zakelj, Maja
Strojan, Primoz
Trojanowski, Maciej
Dyzmann-Sroka, Agnieszka
Kubiak, Anna
Gasparotto, Chiara
Defourny, Noémie
Malicki, Julian
Dunscombe, Peter
Coffey, Mary
Lievens, Yolande
author_role author
author2 Barton, Michael
Grau, Cai
Corral, Julieta
Verhoeven, Rob
Lemmens, Valery
Eycken, Liesbet van
Henau, Kris
Primic-Zakelj, Maja
Strojan, Primoz
Trojanowski, Maciej
Dyzmann-Sroka, Agnieszka
Kubiak, Anna
Gasparotto, Chiara
Defourny, Noémie
Malicki, Julian
Dunscombe, Peter
Coffey, Mary
Lievens, Yolande
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Gestió hospitalària
Gestió de personal
Radioteràpia
Europa
Enquestes
Radiologia
Equipaments sanitaris
Hospital administration
Personnel management
Radiotherapy
Europe
Surveys
Radiology
Health facilities
topic Gestió hospitalària
Gestió de personal
Radioteràpia
Europa
Enquestes
Radiologia
Equipaments sanitaris
Hospital administration
Personnel management
Radiotherapy
Europe
Surveys
Radiology
Health facilities
description Background and purpose: The impact of differences in the distribution of major cancer sites and stages at diagnosis among 4 European countries on the optimal utilization proportion (OUP) of patients who should receive external beam radiotherapy was assessed within the framework of the ESTRO-HERO project. Materials and methods: Data from Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used. Population based stages at diagnosis from the cancer registries of Belgium, Slovenia, the Greater Poland region of Poland, and The Netherlands were used to assess the OUP for each country. A sensitivity analysis was carried out. Results: The overall OUP by country varied from the lowest of 48.3% in Australia to the highest of 53.4% in Poland; among European countries the variation was limited to 3%. Cancer site specific OUPs showed differences according to the variability in stage at diagnosis across countries. The most important impact on the OUP by country was due to changes in relative frequency of tumours rather than stage at diagnosis. Conclusions: This methodology can be adapted using European data, thus facilitating the planning of resources required to cope with the demand for radiotherapy in Europe, taking into account the national variability in cancer incidence.
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/67256
url https://hdl.handle.net/2445/67256
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.radonc.2015.04.021
Radiotherapy and Oncology, 2015, vol. 116, num. 1, p. 45-50
http://dx.doi.org/10.1016/j.radonc.2015.04.021
dc.rights.none.fl_str_mv (c) Elsevier B.V., 2015
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Elsevier B.V., 2015
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Articles publicats en revistes (Ciències Clíniques)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403450623655936
score 15,300719